Hepatocellular Carcinoma — Research

Hepatocellular Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	121,453	`("Carcinoma, Hepatocellular"[mh] OR "Adult Liver Cancer"[mh] OR "Carcinoma, Liver Cell"[mh] OR "Hepatomas"[mh] OR "Liver Cell Carcinoma, Adult"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	31,541	`("Carcinoma, Hepatocellular"[mh] OR "Adult Liver Cancer"[mh] OR "Carcinoma, Liver Cell"[mh] OR "Hepatomas"[mh] OR "Liver Cell Carcinoma, Adult"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	5,018	`("Carcinoma, Hepatocellular"[mh] OR "Adult Liver Cancer"[mh] OR "Carcinoma, Liver Cell"[mh] OR "Hepatomas"[mh] OR "Liver Cell Carcinoma, Adult"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (18)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–18 of 18 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
· Mod Pathol · 2015 · PMID 25698061 · validated civic_curation pubmed
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.
· Science · 2014 · PMID 24578576 · validated civic_curation pubmed
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
· Gastroenterology · 2015 · PMID 25557953 · validated civic_curation pubmed
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
· Cancer Discov · 2019 · PMID 31575541